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Abstract 
Background: To investigate the choroidal thickness in older patients with central serous chorioretinopathy (CSCR) 
compared to age-matched normal subjects.
Methods: Fifteen patients (30 eyes) with CSCR, all aged ≥60 years, and 21 age-matched normal subjects (21 eyes) 
underwent high-definition raster scanning using SD-OCT. Both eyes from CSCR patients were included in the analysis. 
The eyes in patients with CSCR were divided into two groups: active CSCR (17 eyes) if there was foveal-involving sub-
retinal fluid and inactive contralateral eye group (13 eyes). Choroidal thickness was measured from the posterior edge 
of the retinal pigment epithelium to the choroidal–scleral junction at 500 µm intervals up to 2500 µm temporal and 
nasal to the fovea (11 locations).
Results: The mean age of the patients with CSCR was 68.87 ± 6.83 years (mean ± standard deviation). Reliable meas-
urements of choroidal thickness were obtainable in 70.6 % of eyes examined. The choroid was statistically significantly 
thicker in eyes with both active CSCR (P < 0.001) and inactive contralateral eyes (P < 0.01) when compared to normal 
age-matched eyes. The subfoveal choroid was 95 µm (P < 0.01) thicker in eyes with active CSCR (338.05 ± 31.42 µm) 
compared with normal eyes (243.05 ± 13.39 µm). The subfoveal choroid thickness in the inactive contralateral eyes 
was numerically greater than normal, and it was not statistically significantly thicker compared to the normal eyes (dif-
ference—55.68 µm, P > 0.05).
Conclusion: Choroid in older patients with active CSCR was thicker than the choroid in age-matched normal eyes. It 
is important to consider CSCR as a differential diagnosis of serous retinal detachment in elderly patients with thick-
ened choroid and to consider SD-OCT as an imaging modality by which to evaluate the choroidal thickness.
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Background
Central serous chorioretinopathy (CSCR) is a disease 
characterized in its active phase by a serous detachment 
of the neurosensory retina. On optical coherence tomog-
raphy (OCT), active CSCR appears as an elevation of the 
full thickness neurosensory retina from the highly reflec-
tive retinal pigmented epithelium (RPE) separated by 
an optically empty zone. This condition has been linked 
to increased choroidal vascular permeability [1]. Stud-
ies using indocyanine green (ICG) angiography support 
this hypothesis and typically show broad and or multi-
focal areas of choroidal hyperpermeability surrounding 
active RPE leaks [2–4]. This vascular hyper-permeability 
not only increases the choroidal vascular pressure but 
is believed to be a causative factor that leads to damage 
in the RPE, causing pigment epithelial detachment and 
finally, serous retinal detachment [5].
Recent investigations using two different spectral 
domain optical coherence tomography (SD-OCT) 
devices, Cirrus (Carl Zeiss Meditec, Inc., Dublin, CA) 
[6] and Spectralis (Heidelberg Engineering, Heidel-
berg, Germany) [7], demonstrated an increased cho-
roidal thickness in patients with acute CSCR. Using 
Spectralis (Heidelberg Engineering) the mean subfoveal 
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choroidal thickness in 28 eyes of 19 patients with CSCR 
(505  ±  124  µm; interquartile range, 439–573  µm) was 
214 µm (85 %) greater than the previously reported mean 
subfoveal choroidal thickness of normal eyes (P ≤ 0.001).
Although CSCR typically occurs in young healthy male 
individuals, this condition can occur in older patients as 
well [8–10]. In such cases, a diagnostic and therapeutic 
challenge may exist since CSCR, choroidal neovasculariza-
tion secondary to neovascular age-related macular degen-
eration (nAMD) and polypoidal choroidal vasculopathy 
(PCV) can all cause serous retinal detachment [11–14]. 
More recently, in a new hypothesis that proposes to unify 
CSCR and PCV entities into a single disease spectrum, 
CSCR has been described along with PCV as a late-stage 
manifestation of pachychoroid disease of the macula [15].
This study was designed to measure the choroidal 
thickness in patients older than 60 years with CSCR com-
pared to age-matched normal subjects.
Methods
Subjects
A retrospective analysis was performed on 30 eyes of 15 
patients with CSCR older than 60  years of age, and 21 
eyes of 21 age-matched normal patients, who underwent 
high-definition (HD) 1-line raster scanning using Cirrus 
HD-OCT at the New England Eye Center, Tufts Medical 
Center, Boston, Massachusetts, between January 2010 
and June 2011. The age-matched normal subjects had 
normal visual acuity and did not have any retinal or cho-
roidal pathology on ophthalmoscopy.
The diagnosis of CSCR was based on history, clinical 
examination, fluorescein angiography, ICG angiogra-
phy and SD-OCT findings. Eyes that had subretinal fluid 
were defined as having “active” CSCR. Eyes with active 
CSCR that manifested fluid for more than 4  months or 
presented more than two recurrent episodes were further 
defined as having active, chronic CSCR.
All patients had both eyes scanned with SD-OCT. Two 
patients (2 of 15 patients (11.8 %)] presented with active 
CSCR in both eyes during the study period and both eyes 
were included in the analysis as active, acute CSCR. The 
other patients [13 of 15, 26 of 30 eyes (88.2 %)] presented 
with active CSCR in only one eye. In these patients, the 
contralateral eyes were included as the “inactive con-
tralateral eye” group. Patients with other ocular disease 
and uncontrolled systemic disease, phakic patients with 
a spherical equivalent ≥ ±3.00 diopters, and pseudopha-
kic patients with myopic fundus were excluded from the 
analysis were excluded from this study.
Choroidal thickness measurement
The scan pattern used on Cirrus HD-OCT was the 
HD 1-line raster. It is a 6-mm line consisting of 4096 
A-scans. Images were taken with the vitreoretinal inter-
face adjacent to the zero-delay. The HD 1-line raster has 
20 B-scans averaged together without tracking. To be 
included in this study, images had to be at least 6 out of 
10 in intensity and taken as close to the fovea as possible, 
which would lead to imaging at the thinnest point of the 
macula. However, it is important to note that slight dif-
ferences in positioning could affect the measured thick-
nesses. Enhanced depth imaging (EDI) was not employed 
as it was not available on the Cirrus SD-OCT during the 
study period.
Using the Cirrus linear measurement tool, 2 independ-
ent observers measured choroidal thickness perpendicu-
larly from the outer edge of the hyper-reflective RPE to 
the sclerochoroidal junction at 500-µm intervals tem-
poral and nasal from the fovea, up to 2500 µm (11 loca-
tions). Furthermore, the central foveal thickness was also 
measured at this time in order to determine the correla-
tion between central retinal thickness and subfoveal cho-
roidal thickness in the eyes with active CSCR.
Statistical analysis
Data are expressed as mean ± standard error of the mean 
(SEM). Statistical analyses were performed using one-
way analysis of variance (ANOVA) followed by post test 
comparison with Bonferroni’s Multiple Test. Pearson cor-
relation coefficient was used to evaluate the correlation 
between the subfoveal choroidal thicknesses and central 
foveal thickness. A 95  % confidence interval and a 5  % 
level of significance were adopted; therefore, the results 
with a P value less than or equal to 0.05 were considered 
significant. All statistics were calculated using Graph Pad 
Prism 5.0 software for Macintosh.
Results
Seventeen eyes of 15 patients (11 men and 4 women) 
with active CSCR and 13 inactive contralateral eyes 
(without CSCR) were retrospectively studied. Patient age 
ranged from 60 to 79 years (mean ± standard deviation, 
68.87 ± 6.83 years). Six patients (6 eyes) presented with 
acute active CSCR and 9 patients (11 eyes) were diag-
nosed as chronic active CSCR. The most common sys-
temic condition was systemic hypertension [7 patients 
(46 %)]. One patient had a history of treated breast can-
cer and another had previously treated prostate can-
cer; both had no known ocular metastases. One of the 
patients was concurrently using inhaled corticosteroids 
for asthma. Additionally, 21 age-matched normal sub-
jects (mean  ±  standard deviation, 64.59  ±  8.79  years) 
without any ocular or systemic disease were evaluated.
Reliable measurements of choroidal thickness were 
obtainable in 70.6 % of the eyes with active CSCR (12 of 
17 eyes) and in 84.6 % of the contralateral eyes (11 of 13 
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eyes). Measurements were considered reliable if the cho-
roidal–scleral junction could be measured. In the eyes 
where the choroidal–scleral junction could not clearly 
be identified, the extent of choroidal thickness may cause 
a loss of signal penetration and intensity at increas-
ing depths because of sensitivity roll-off distal to the 
zero-delay line (Fig. 1). Furthermore, signal degradation 
could be secondary to fibrin deposition within the serous 
detachment or due to cataracts. All such eyes had choroi-
dal thickness in excess of 450 µm.
Mean choroidal thickness at each location was plotted 
in Fig. 2. The choroidal thickness in the eyes with active 
CSCR (P  <  0.001) and the contralateral eyes (P  <  0.01) 
was significantly thicker when comparing with normal 
age-matched eyes. Moreover, eyes with the active CSCR 
presented with a thicker choroid when compared to the 
contralateral eye. (P  <  0.05). Representative images are 
shown in Fig. 3.
Table 1 shows the average choroidal thickness in each 
location. The choroid was noted to be thinnest nasally, 
thicker in the subfoveal region, and then thinner again 
temporally (however, not as thin as the choroid proximal 
to the disc). This pattern was observed in the eyes with 
active CSCR and in the inactive contralateral eyes. Simi-
lar results were also observed in normal subjects [16–19].
The subfoveal choroidal thickness was noted 
to be increased in the eyes with active CSCR 
(338.05  ±  31.42  µm) compared with normal eyes 
(243.05  ±  13.39  µm), difference of 95.00  µm, P  <  0.01 
(Fig.  4). The subfoveal choroid thickness in the inactive 
contralateral eyes was numerically greater than normal, 
and it was not statistically significantly thicker compared 
to the normal eyes (difference—55.68 µm, P > 0.05).
The correlation between central foveal thickness of 
the retina and subfoveal choroidal thickness was also 
examined. No statistical correlation between these 2 
measurements was noted in the eyes with active CSCR 
(r = 0.2115, P = 0.487) suggesting that retinal thickness 
may not be directly related to choroidal thickness in this 
group.
Discussion
CSCR occurs most commonly in men aged 30–50 years 
of age [20]. However with the aging of the population 
and advances in posterior segment imaging, the number 
of older patients with the diagnosis of CSCR appears to 
be either increasing or our ability to detect is now more 
sensitive [8]. In patients over the age of 60, neurosensory 
detachments may occur as a result of several chorioreti-
nal diseases, most notably nAMD, which makes diagnos-
ing this condition in this age group a diagnostic challenge 
[8, 11].
Several studies suggest that an increase in the perme-
ability of the choriocapillaris might be the primary cause 
of damage to the overlying retinal pigment epithelium, 
which would not be able to pump in a retinochoroidal 
direction [3, 21]. This theory supports previous stud-
ies, which have shown increased choroidal thickness in 
young patients. However, these studies evaluated patients 
with an average age less than 60 years.
This study investigates the choroidal thickness of 
patients older than 60 years (mean ± standard deviation, 
68.87 ±  6.83 years) with active CSCR. In these patients 
the choroid was found to be thicker in the eyes with sub-
retinal fluid (active CSCR) and in the inactive contralat-
eral eye, when compared with age-matched normal eyes. 
In a recent publication with a younger group of CSCR 
Fig. 1 High definition 1-line optical coherence tomography B-scan 
image from a 72-year-old man with active central serous chorioretin-
opathy. Serous detachment of the neurosensory retina (asterisk). In 
this eye the choroid may be so thick that it is not possible to visualize 
the choroidal-sclera interface (arrows)
Fig. 2 Graph of mean choroidal thickness in normal eyes, eyes with 
active central serous chorioretinopathy (CSCR) and inactive con-
tralateral eye. Mean choroidal thickness at each of the 11 locations 
measured at 500 µm (0.5 mm) intervals temporal (T) and nasal (N), 
centered on the fovea. Active: eyes with active CSCR; contralateral: 
inactive contralateral eyes. P value represents the result of statistical 
analyses (ANOVA)
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patients, Chung et  al. showed that the subfoveal cho-
roidal thickness and the thickness of Haller layer were 
increased in the affected and the unaffected fellow eyes 
compared to healthy subjects [22]. This finding is impor-
tant for two reasons. First, noting a thickened choroid in 
a patient with neurosensory retinal detachment could 
Fig. 3 Representative images of an elderly patient with active chronic central serous chorioretinopathy (CSCR) for 8 months. a Fundus color 
photograph shows pigmentary changes on the macula area, which corresponds to a leakage point on the dye-based angiographies. b Fluorescein 
angiography image shows a focal area of leakage (white arrow). c Late phase of an indocyanine green angiography shows multiple areas of choroi-
dal hyperpermeability. d SD OCT foveal B-scan shows subretinal and intraretinal fluid. The perpendicular green line was drawn from posterior edge 
of retinal pigment epithelium to choroidal–scleral junction to demonstrate the measurement. The green arrow heads point the choroidal–scleral 
junction
Table 1 Mean choroidal thickness at each of the 11 locations
 Active: eyes with active central serous chorioretinopathy; contralateral: inactive contralateral eyes. P values represent the results of statistical analyses (ANOVA)
Location (mm from fovea) Mean choroidal thickness (µm) P
Normals Active Contralateral
Temporal (2.5) 193.72 ± 14.45 274.22 ± 26.58 221.90 ± 24.47 0.047
Temporal (2.0) 217.05 ± 9.42 289.30 ± 27.70 229.00 ± 29.47 0.031
Temporal (1.5) 225.34 ± 9.60 304.35 ± 24.05 262.60 ± 32.51 0.013
Temporal (1.0) 231.58 ± 10.46 312.00 ± 28.39 276.00 ± 35.91 0.017
Temporal (0.5) 233.96 ± 14.25 320.80 ± 27.49 277.44 ± 38.67 0.013
Subfoveal 243.05 ± 13.39 338.05 ± 31.42 297.40 ± 33.74 0.001
Nasal (0.5) 236.29 ± 13.60 323.70 ± 23.15 309.09 ± 39.70 0.0009
Nasal (1.0) 226.34 ± 12.16 297.30 ± 21.86 286.45 ± 35.48 0.002
Nasal (1.5) 197.90 ± 12.84 278.00 ± 22.56 256.27 ± 31.44 0.0004
Nasal (2.0) 169.00 ± 14.56 251.40 ± 25.98 211.00 ± 23.13 0.0003
Nasal (2.5) 143.67 ± 13.03 235.00 ± 31.49 174.90 ± 19.20 0.0002
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help differentiate CSCR and PCV from nAMD in older 
adults [23, 24]. It is well known that choroidal thinning 
occurs in normal eyes as we get older. It is believed that 
over the age of 50 the choroidal thickness ranges from 
203.6 to 287  µm, it is also believed that this value con-
tinues to decrease by 14–15.6 µm every 10 years [17, 18, 
25]. The choroid is also significantly thinner in patients 
with nAMD [23, 24, 26, 27]. Based on these studies, older 
patients with subretinal fluid, but no other manifestations 
of nAMD who have a choroidal thickness greater than 
300 µm appear more likely to have CSCR. However, it is 
not possible to differentiate CSCR from nAMD based on 
the choroidal thickness alone. Information which can be 
acquired from a clinical examination and dye-based angi-
ography are critical to make this distinction. Second, the 
OCT findings provide additional evidence that CSCR in 
adults older than 60  years may be caused by increased 
hydrostatic pressure in the choroid. Based on our results, 
we propose a cut-off value of 320  µm, above which the 
choroid can be considered thickened in patients older 
than 60 years. In this study, we did not note any normal 
subjects with a choroidal thickness above this value.
As aforementioned, CSCR has been described along with 
PCV as a late-stage manifestation of pachychoroid dis-
ease of the macula [15]. Dansingani et al. [28] analyzed the 
swept-source OCT en face imaging of patients with differ-
ent diseases of the pachychoroid spectrum and noted that 
dilated choroidal vessels were also seen in eyes without 
manifest pathology, suggesting that pachychoroid is a bilat-
eral phenomenon and that it may have a systemic basis. In 
a recent report, Lehmann et al. [29] have proposed that the 
pachychoroid morphology may have a genetic basis with a 
dominant mode of inheritance. This theory is in line with 
our results, which showed that both eyes with active CSCR 
and eyes with inactive CSCR presented a significantly 
thickened choroid compared to age-matched normals.
The measurement of the choroid was not possible in 5 
eyes (29.4 %) with active CSCR and in two inactive con-
tralateral eyes (15.4 %). This is likely due to a loss of signal 
penetration and intensity due to the increased thickness 
of the choroid. The SD-OCT imaging system is most sen-
sitive to signals coming from reflectors close to the zero-
delay; as a reflector is moved away from the zero-delay, 
the system will become less sensitive to the back-reflected 
signals [7]. Improvements in EDI SD-OCT allow for bet-
ter visualization of choroidal features. This methodology 
works by displacing the instrument more forward than 
in normal OCT imaging. The inverted image allows the 
choroid to be located closer to the zero-delay, improving 
visualization [16]. However, this technology was not pre-
sent on the Cirrus SD-OCT during the study period. In 
this study a higher percentage of patients (70.6  %) with 
active CSCR could be measured when compared with 
previous study from our group that evaluated younger 
patients with CSCR (30.8 %) [6]. This difference may be 
explained by the signal degradation secondary to the 
densely retinal pigmented epithelium of younger patients 
which was noted in previous investigations.
Previous studies showed that choroidal thickness pre-
sents a significant circadian pattern with higher values 
at night and lower values during the day in young adults 
[30–32]. However, It’s worth noting that diurnal fluctua-
tion of choroidal thickness could not be accessed due to 
the retrospective nature of our study.
Conclusion
In conclusion, this study showed that the choroid in older 
patients with active CSCR was thicker than the choroid 
in age-matched normal eyes. It is important to consider 
CSCR as a differential diagnosis in elderly patients and 
to consider SD-OCT as an imaging modality by which 
to evaluate the choroidal thickness. Choroidal thickness 
should be considered when making a diagnosis of CSCR, 
especially in the older population in which determin-
ing the underlying cause of serous retinal detachment is 
challenging.
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Fig. 4 a Scatter plot of subfoveal choroidal thickness in normal eyes, 
eyes with active central serous chorioretinopathy (CSCR) and the 
inactive contralateral eye. Active: eyes with active CSCR; contralateral: 
inactive contralateral eyes. b Distribution of subfoveal choroidal thick-
ness of eyes presenting with active CSCR, comparing with normal 
eyes. SEM standard error of the mean
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